Moffitt Cancer Center is joining a national pilot project being conducted by the American Society of Clinical Oncology and the Association of Community Cancer Centers. The project is testing a research site self-assessment tool and an implicit bias training program designed to increase racial and ethnic diversity among individuals with cancer participating in clinical trials.

The experience of a fruit fly dying from cancer may seem worlds away from that of a human with a life-threatening tumor, yet researchers are discovering commonalities between the two that could reveal ways to improve the survival of cancer patients.

A new study, published in the New England Journal of Medicine, finds a single dose of typhoid conjugate vaccine (TCV) – the only typhoid vaccine licensed for children as young as 6 months – is safe and 84 percent effective in protecting against typhoid in Blantyre, Malawi.

Research conducted by scientists from the University of Basel has shown that it may be possible to improve the treatment of leukemia by additionally inhibiting a specific signaling pathway.

A team of researchers has developed a new system intended to treat infertility in women with thin endometria that works by delivering a compound known to stimulate the growth of blood vessels, thickening the lining of the uterus.

Using a virus that grows in black-eyed pea plants, nanoengineers have developed a new treatment that could protect and the lungs from metastatic cancer.

Scientists are exploiting the latest advances in single-molecule detection to explore the enzymatic activity involved in gene repair. Further research in this area could lead to technologies for targeted gene repair and drug development.

In a study published this month in Communications Biology, researchers from Tokyo Medical and Dental University (TMDU) have revealed that the protein HMGB1 is a key player in both frontotemporal lobar degeneration and Alzheimer disease, two of the most common causes of dementia.

The hypothesis that raising the brain levels of the natural antioxidant urate could slow the progression of Parkinson’s disease (PD) has been disproven by researchers at Massachusetts General Hospital (MGH).

Glioblastoma's dependency on biotin distribution suggests that biotin-dependent metabolism and epigenetic pathways could be targeted therapeutically to treat the disease.